- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01496859
Observational Study of Baska Mask, a New Supraglottic Airway Device
March 23, 2012 updated by: John Laffey, University College Hospital Galway
The Baska mask is a new supraglottic airway device .
The investigators would like to assess its performance in setting in which the current standard - LMA device - is being used.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Our group has performed a number of studies on novel airway devices.
In this study we would like to evaluate a new supraglottic airway named Baska mask.
We would like to monitor certain parameters (time to and ease of insertion, failure rate, seal pressures, complications etc) as regarding the performance and safety profile of this device.
This is a descriptive case series of patients undergoing airway management under general anaesthesia.
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Galway, Ireland
- Galway University Hospitals
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Written informed Consent
- No relevant drug allergies
- Body-mass index (BMI) 20-35
- Age 18-65
- Non-urgent surgery of planned duration 0-2 hrs
Exclusion Criteria:
- Inability of patient/parent to understand or consent for the trial
- Non-English speakers
- Neck pathology
- Previous or anticipated problems with the upper airway or upper GI tract (reflux, hiatus hernia, oropharyngeal tumour, upper respiratory tract infection in the last 10 days etc)
- BMI >35
- Expected Difficult airway
- Live Pregnancy
- Increased risk for Gastric Aspiration
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Baska
|
use of a supraglottic airway device as a standard part of a general anaesthetic
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Device Placement Success rate
Time Frame: within 30 mins of anaesthesia commencement
|
within 30 mins of anaesthesia commencement
|
|
|
time to placement of device
Time Frame: within 30 mins of anaesthesia commencement
|
from the moment the device touched until successful ventilation achieved or device removed
|
within 30 mins of anaesthesia commencement
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
airway leak pressure of the device
Time Frame: within 30 mins of anaesthetic commencement
|
within 30 mins of anaesthetic commencement
|
|
|
user-rated ease of insertion of device
Time Frame: within 30 mins of anaestesia commencement
|
10cm visual analog score to be used
|
within 30 mins of anaestesia commencement
|
|
complication rates
Time Frame: From the moment general anaesthesia commenced up to 1 day postoperatively
|
complications specifically monitored will be desaturation episodes, laryngospasm, blood staining of the device, lip damage.
We will record other complications related to the use of the device, including but not limited to loss of airway with need to manioulate mask/switch to alternative device, regurgitation, aspiration, teeth damage.
|
From the moment general anaesthesia commenced up to 1 day postoperatively
|
|
patient comfort indices
Time Frame: from the moment the patient awake up to 1 day postoperatively
|
Throat pain, dysphagia and dysphonia will be assessed.
10 point verbal rating scale will be used
|
from the moment the patient awake up to 1 day postoperatively
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: John G Laffey, FFARCSI, National University of Ireland, Galway and Galway University Hospitals
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2011
Primary Completion (Actual)
December 1, 2011
Study Completion (Actual)
December 1, 2011
Study Registration Dates
First Submitted
December 18, 2011
First Submitted That Met QC Criteria
December 20, 2011
First Posted (Estimate)
December 21, 2011
Study Record Updates
Last Update Posted (Estimate)
March 26, 2012
Last Update Submitted That Met QC Criteria
March 23, 2012
Last Verified
March 1, 2012
More Information
Terms related to this study
Other Study ID Numbers
- C.A.621
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Performance and Safety of a New Supraglottic Airway Device
-
John LaffeyCompletedPerformance and Safety of an Airway Management DeviceIreland
-
University College Hospital GalwayCompletedPerformance and Safety of an Airway Management DeviceIreland
-
John LaffeyCompletedPerformance and Safety of an Airway Management DeviceIreland
-
Seoul National University HospitalCompletedAirway Complication of Anesthesia | Intubation; Difficult or Failed | Supraglottic Airway DeviceKorea, Republic of
-
University Health Network, TorontoCompletedThe Study Focuses on the Effect of a New Supraglottic Airway With Built-in Cuff Pressure Indicator on Postoperative Pharyngolaryngeal Adverse EventsCanada
-
Titan Condoms, LLCSTATCure Consulting Services Inc.Not yet recruitingPerformance of a New Condom
-
Aretaieio HospitalCompletedEndotracheal Intubation | Airway Management | Supraglottic Airway Device | Regional AnesthesiaGreece
-
Asan Medical CenterCompletedPediatric ALL | Temperature Change, Body | Supraglottic Airway DeviceKorea, Republic of
-
Nano PharmaSolutions AustraliaCMAX Clinical Research Pty Limited; Beyond Drug DevelopmentCompletedTolerability of NT-301 Nasal Spray | Pharmacokinetics of NT-301 Nasal Spray | Safety of NT-301 Nasal Spray | Performance of NT-301 Nasal Spray DeviceAustralia
-
University of Colorado, DenverCompletedFunctionality and Performance of DeviceUnited States
Clinical Trials on Placement and use of Baska mask
-
University College Hospital GalwayCompletedDetermination of the Best Predictor for Correct Baska Mask SizeIreland
-
John LaffeyCompletedBaska Mask Efficacy and Safety in ChildrenIreland
-
University of MalayaCompleted
-
Reham Ali Abdelhaleem AbdelrahmanCompleted
-
Samsun UniversityCompleted
-
Adiyaman University Research HospitalTurkiye Yuksek Ihtisas Education and Research HospitalCompleted
-
MetroHealth Medical CenterCompletedParalysis | Spinal Cord InjuriesUnited States
-
John LaffeyCompletedPerformance and Safety of an Airway Management DeviceIreland
-
University College Hospital GalwayCompletedPerformance and Safety of an Airway Management DeviceIreland